CDPPB is a drug used in scientific research which acts as a positive allosteric modulator selective for the metabotropic glutamate receptor subtype mGluR5. It has antipsychotic effects in animal models and mGluR5 modulators are under investigation as potential drugs for the treatment of schizophrenia as well as other applications.
This page contains content from the copyrighted Wikipedia article "CDPPB"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
